Adjuvant nab-paclitaxel plus S-1 versus oxaliplatin plus capecitabine after curative D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase 3 open-label, randomized controlled trial

被引：0
|
作者：
Yu Pengfei
Du, Yian
Xu, Zhiyuan
Yang, Litao
Ying, Jieer
Chen, Ping
Wei, Yunhai
Wu, Yingjie
Yan, Zhilong
Xu, Hongtao
Zhang, Xiaojing
Li, Yong
Zheng, Zhichao
Chen, Zhiheng
Cheng, Xiangdong
机构：
[1] Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
[2] Ningbo Second Hosp, Ningbo, Peoples R China
[3] Zhejiang Univ, Huzhou Hosp, Huzhou Cent Hosp, Huzhou, Peoples R China
[4] Ningbo Univ, Affiliated Peoples Hosp, Ningbo, Peoples R China
[5] Ningbo First Hosp, Ningbo, Peoples R China
[6] Lishui Cent Hosp, Lishui, Peoples R China
[7] Huzhou Teachers Coll, Affiliated Hosp, 1 Peoples Hosp Huzhou, Huzhou, Peoples R China
[8] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
[9] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[10] First Hosp Jiaxing, Jiaxing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
386
引用
收藏
页码：386 / 386
页数：1
相关论文
共 50 条
  • [21] Adjuvant nab-Paclitaxel plus Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open -Label, Phase III Trial
    Tempero, Margaret A.
    Pelzer, Uwe
    O'Reilly, Eileen M.
    Winter, Jordan
    Oh, Do-Youn
    Li, Chung-Pin
    Tortora, Giampaolo
    Chang, Heung-Moon
    Lopez, Charles D.
    Bekaii-Saab, Tanios
    Ko, Andrew H.
    Santoro, Armando
    Park, Joon Oh
    Noel, Marcus S.
    Frassineti, Giovanni Luca
    Shan, Yan-Shen
    Dean, Andrew
    Riess, Hanno
    Van Cutsem, Eric
    Berlin, Jordan
    Philip, Philip
    Moore, Malcolm
    Goldstein, David
    Tabernero, Josep
    Li, Mingyu
    Ferrara, Stefano
    Le Bruchec, Yvan
    Zhang, George
    Lu, Brian
    Biankin, Andrew V.
    Reni, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (11) : 2007 - +
  • [22] Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
    Noh, Sung Hoon
    Park, Sook Ryun
    Yang, Han-Kwang
    Chung, Hyun Cheol
    Chung, Ik-Joo
    Kim, Sang-Woon
    Kim, Hyung-Ho
    Choi, Jin-Hyuk
    Kim, Hoon-Kyo
    Yu, Wansik
    Lee, Jong Inn
    Shin, Dong Bok
    Ji, Jiafu
    Chen, Jen-Shi
    Lim, Yunni
    Ha, Stella
    Bang, Yung-Jue
    LANCET ONCOLOGY, 2014, 15 (12): : 1389 - 1396
  • [23] S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial
    Hironaka, Shuichi
    Sugimoto, Naotoshi
    Yamaguchi, Kensei
    Moriwaki, Toshikazu
    Komatsu, Yoshito
    Nishina, Tomohiro
    Tsuji, Akihito
    Nakajima, Takako Eguchi
    Gotoh, Masahiro
    Machida, Nozomu
    Bando, Hideaki
    Esaki, Taito
    Emi, Yasunori
    Sekikawa, Takashi
    Matsumoto, Shigemi
    Takeuchi, Masahiro
    Boku, Narikazu
    Baba, Hideo
    Hyodo, Ichinosuke
    LANCET ONCOLOGY, 2016, 17 (01): : 99 - 108
  • [24] Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE) final report of a randomised, open-label, phase 3 trial
    Zhang, Xiaotian
    Liang, Han
    Li, Ziyu
    Xue, Yingwei
    Wang, Yanong
    Zhou, Zhiwei
    Yu, Jiren
    Bu, Zhaode
    Chen, Lin
    Du, Yian
    Wang, Xinbao
    Wu, Aiwen
    Li, Guoli
    Su, Xiangqian
    Xiao, Gang
    Cui, Ming
    Wu, Dan
    Chen, Li
    Wu, Xiaojiang
    Zhou, Yanbing
    Zhang, Lianhai
    Dang, Chengxue
    He, Yulong
    Zhang, Zhongtao
    Sun, Yihong
    Li, Yong
    Chen, Huanqiu
    Bai, Yuxian
    Wang, Yakun
    Yu, Peiwu
    Zhu, Guanbao
    Suo, Jian
    Jia, Baoqing
    Li, Leping
    Huang, Changming
    Li, Fei
    Ye, Yingjiang
    Xu, Huimian
    Wang, Xin
    Yuan, Yannan
    Jianyu, E.
    Ying, Xiangji
    Yao, Chen
    Shen, Lin
    Ji, Jiafu
    LANCET ONCOLOGY, 2025, 26 (03): : 312 - 319
  • [25] Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study
    Jin, Min
    Liu, Hong-Li
    Xue, Jun
    Ma, Hong
    Liu, Jun-Li
    Lin, Zhen-Yu
    Wang, Jing
    Bao, Le-Qun
    Luo, Zhi-Guo
    Yu, Xiong-Jie
    Li, Shuang
    Hu, Jian-Li
    Zhang, Tao
    ONCOLOGIST, 2024, 29 (10): : e1406 - e1418
  • [26] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604).
    Matsuyama, Jin
    Tamura, Shigeyuki
    Fujitani, Kazumasa
    Kimura, Yutaka
    Tsuji, Takeshi
    Iijima, Shohei
    Imamura, Hiroshi
    Inoue, Kentaro
    Kobayashi, Kenji
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [27] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 1002)
    Matsuyama, Jin
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Imamura, Hiroshi
    Fujita, Junya
    Iljima, Shohei
    Ueda, Shugo
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Satoh, Taroh
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604)
    Fujitani, K.
    Tamura, S.
    Kimura, Y.
    Tsuji, T.
    Matsuyama, J.
    Iijima, S.
    Imamura, H.
    Kurokawa, Y.
    Tsujinaka, T.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
    Nozomu Fuse
    Hideaki Bando
    Keisho Chin
    Seiji Ito
    Takaki Yoshikawa
    Akira Tsuburaya
    Masanori Terashima
    Yoshiyuki Kawashima
    Tetsu Fukunaga
    Masahiro Gotoh
    Yasunori Emi
    Kazuhiro Yoshida
    Eiji Oki
    Seiji Takahashi
    Hiroshi Kuriki
    Kumi Sato
    Mitsuru Sasako
    Gastric Cancer, 2017, 20 : 332 - 340
  • [30] Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
    Fuse, Nozomu
    Bando, Hideaki
    Chin, Keisho
    Ito, Seiji
    Yoshikawa, Takaki
    Tsuburaya, Akira
    Terashima, Masanori
    Kawashima, Yoshiyuki
    Fukunaga, Tetsu
    Gotoh, Masahiro
    Emi, Yasunori
    Yoshida, Kazuhiro
    Oki, Eiji
    Takahashi, Seiji
    Kuriki, Hiroshi
    Sato, Kumi
    Sasako, Mitsuru
    GASTRIC CANCER, 2017, 20 (02) : 332 - 340
12345